Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Lidia Mak"'
Autor:
Patricia Ohana, Yasmine Amitay, Lidia Mak, Hilary Shmeeda, Jenny Gorin, Alberto A. Gabizon, Dina Tzemach
Publikováno v:
Cancer drug resistance (Alhambra, Calif.). 4(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::900cafd5344973f035b57aea3c99982a
https://pubmed.ncbi.nlm.nih.gov/35582027
https://pubmed.ncbi.nlm.nih.gov/35582027
Autor:
Patricia Ohana, Yogita Patil, Lidia Mak, Hilary Shmeeda, Alberto Gabizon, Jenny Gorin, Yasmine Amitay, Dina Tzemach
Publikováno v:
Pharmaceutical Research. 33:686-700
Pegylated liposomal (PL) mitomycin C lipid-based prodrug (MLP) has recently entered clinical testing. We studied here the preclinical pharmacology of PL-MLP. The stability, pharmacokinetics, biodistribution, and other pharmacologic parameters of PL-M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::657f9bb7a802d733255e7636ce30c8c3
https://doi.org/10.1007/s11095-015-1819-7
https://doi.org/10.1007/s11095-015-1819-7
Autor:
Stephan T. Stern, Alberto Gabizon, Yasmine Amitay, Lidia Mak, Hilary Shmeeda, Yechezkel Barenholz, Jenny Gorin, Dina Tzemach
Publikováno v:
Journal of drug targeting. 24(9)
We developed a pegylated liposome formulation of a dissociable salt of a nitrogen-containing bisphosphonate, alendronate (Ald), coencapsulated with the anthracycline, doxorubicin (Dox), a commonly used chemotherapeutic agent. Liposome-encapsulated am
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cacb2b062c619ae146eb2365c54f1cb9
https://pubmed.ncbi.nlm.nih.gov/27187807
https://pubmed.ncbi.nlm.nih.gov/27187807
Autor:
Dina Tzemach, Jenny Gorin, Lidia Mak, Hilary Shmeeda, Samuel Zalipsky, Yasmine Amitay, Alberto Gabizon
Publikováno v:
Cancer Chemotherapy and Pharmacology. 66:43-52
The folate receptor (FR) is overexpressed in a broad spectrum of malignant tumors and represents an attractive target for selective delivery of anti-cancer agents to FR-expressing tumors. Targeting liposomes to the FR has been proposed as a way to en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7b1f96d7e1a7c0b65a19924f2651f97
https://doi.org/10.1007/s00280-009-1132-4
https://doi.org/10.1007/s00280-009-1132-4
Publikováno v:
Journal of Controlled Release. 136:155-160
Background Receptor-directed targeting of ligand-bearing liposomes to tumor cells may enhance therapeutic efficacy by intracellular delivery of a concentrated payload of liposomal drug. The goal of this study was to assess whether Her2-targeted pegyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::342c673eb9426a6fc7a38d996ec389b3
https://doi.org/10.1016/j.jconrel.2009.02.002
https://doi.org/10.1016/j.jconrel.2009.02.002
Autor:
Yasmine Amitay, J. Allen Zhang, Dina Tzemach, Alberto Gabizon, Lidia Mak, Hilary Shmeeda, Kumar Saran, Jenny Gorin, Joerge Ogorka
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 146(1)
Introduction Zoledronic acid (ZOL), a nitrogen-containing bisphosphonate, is a potent inhibitor of farnesyl-pyrophosphate synthase with poor in vitro cytotoxic activity as a result of its limited diffusion into tumor cells. The purpose of this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13ee43fcc010815690a37d8a43149242
https://pubmed.ncbi.nlm.nih.gov/20462513
https://pubmed.ncbi.nlm.nih.gov/20462513
Publikováno v:
Molecular cancer therapeutics. 5(4)
The folate receptor is overexpressed in a broad spectrum of malignant tumors and represents an attractive target for selective delivery of anticancer agents to folate receptor–expressing tumors. This study examines folate-lipid conjugates as a mean
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29a4a9114151ee3a57bbc29940c5988f
https://pubmed.ncbi.nlm.nih.gov/16648551
https://pubmed.ncbi.nlm.nih.gov/16648551
Publikováno v:
Journal of drug targeting. 10(7)
Stealth (pegylated) liposomal doxorubicin (Doxil) has been extensively studied at the pre-clinical and clinical level in recent years. However, one issue not yet addressed is the effect of dose on tumor localization and therapeutic efficacy of Doxil.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::433ea32cf4395fa415d1039a2c3e0f59
https://pubmed.ncbi.nlm.nih.gov/12683721
https://pubmed.ncbi.nlm.nih.gov/12683721
Autor:
Maksym Stetsenko, Tetiana Margitych, Serhii Kryvyi, Lidia Maksimenko, Ali Hassan, Svitlana Filonenko, Βaikui Li, Junle Qu, Elke Scheer, Sergii Snegir
Publikováno v:
Nanomaterials, Vol 10, Iss 3, p 512 (2020)
Here we study the morphology and the optical properties of assemblies made of small (17 nm) gold nanoparticles (AuNPs) directly on silicon wafers coated with (3-aminopropyl)trimethoxysilane (APTES). We employed aliphatic 1,6-hexanedithiol (HDT) molec
Externí odkaz:
https://doaj.org/article/131b55f607f949e98c8fb8d2128b36a0
Autor:
Maksym Stetsenko, Salvatore A. Pullano, Tetiana Margitych, Lidia Maksimenko, Ali Hassan, Serhii Kryvyi, Rui Hu, Chun Huang, Roman Ziniuk, Sergii Golovynskyi, Ivan Babichuk, Βaikui Li, Junle Qu, Antonino S. Fiorillo
Publikováno v:
Nanomaterials, Vol 9, Iss 11, p 1641 (2019)
A straightforward and effective spin-coating technique at 120 °C was investigated for the deposition of a thin nanoporous layer with antireflection properties onto glass and indium tin oxide (ITO) coated glass. A mixture of zeolite 3A powder and hig
Externí odkaz:
https://doaj.org/article/41f1e9c374ef4d24a374f13f1779eb24